Skip to Content

Dear Customer:

The current international situation is complex and volatile, and uncertain tariff policies may potentially impact our product prices. Given these uncertainties, we value your understanding regarding order-related matters.

If you decide to place an order during this period, we reserve the right to adjust the price based on the evolving situation. We understand that market changes may cause inconvenience. We will negotiate with you if there’s a significant price fluctuation due to tariff policy changes before the order’s actual delivery, and in such cases we may adjust or cancel the order as necessary.

Merck
CN

902241

Sigma-Aldrich

N-Hydroxysuccinimide poly(ethylene glycol)-block-poly(lactide-co-glycolide)

PEG average Mn 5000, PLGA average Mn 15000, lactide:glycolide 50:50

Synonym(s):

NHS-PEG-b-PLGA, NHS-PEG-PLGA

Sign Into View Organizational & Contract Pricing

Select a Size

5 ML
CN¥1,818.53
25 ML
CN¥4,521.32
100 ML
CN¥13,875.21
500 ML
CN¥58,467.54

CN¥1,818.53


Available to ship onApril 14, 2025Details


Request a Bulk Order

Select a Size

Change View
5 ML
CN¥1,818.53
25 ML
CN¥4,521.32
100 ML
CN¥13,875.21
500 ML
CN¥58,467.54

About This Item

Linear Formula:
C10H14O5NS(C2H4O)nC2H4O[(C2H2O2)x(C3H4O2)y]mH
UNSPSC Code:
12352111
NACRES:
NA.23

CN¥1,818.53


Available to ship onApril 14, 2025Details


Request a Bulk Order

form

powder

feed ratio

lactide:glycolide 50:50
lactide:glycolide 50:50±5

mol wt

PEG Mn 4000-6000 g/mol (by NMR)
PEG average Mn 5000
PLGA Mn 13500-16500 g/mol (by NMR)
PLGA average Mn 15000

color

white

suitability

conforms to structure for NMR

storage temp.

−20°C

Application

N-Hydroxysuccinimide poly(ethylene glycol)-block-poly(lactide-co-glycolide) is a N-hydroxysuccinimide (NHS)-functionalized, biocompatible, amphiphilic block copolymer. Due to its self-assembling properties, this material can be used in the formation of nanoparticles for drug delivery. Additionally, due to the NHS-functionalization of the PEG block, this material can be used to rapidly covalently conjugate biomolecules, API, or targeting ligands. Potential uses include the targeted and/or controlled release of cancer drugs, anti-inflammatory drugs, antibiotics, or anesthetic agents.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Biodegradable PLGA-b-PEG polymeric nanoparticles: synthesis, properties and nanomedical applications as drug delivery system
Locatelli, E. et al.
Journal of Nanoparticle Research, 14, 1316-1316 (2012)
Ilaria Monaco et al.
Journal of medicinal chemistry, 60(10), 4510-4516 (2017-05-05)
Polymeric nanoparticles (PNPs) may efficiently deliver in vivo therapeutics to tumors when conjugated to specific targeting agents. Gint4.T aptamer specifically recognizes platelet-derived growth factor receptor β and can cross the blood-brain barrier (BBB). We synthesized Gint4.T-conjugated PNPs able of high
Yihan Xu et al.
Journal of biomedical materials research. Part B, Applied biomaterials, 105(6), 1692-1716 (2016-04-22)
Poly (lactic-co-glycolic acid) (PLGA) copolymers have been broadly used in controlled drug release applications. Because these polymers are biodegradable, they provide an attractive option for drug delivery vehicles. There are a variety of material, processing, and physiological factors that impact

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service